Erik Langhoff, MD, PhD

img_Erik Langhoff
ADJUNCT PROFESSOR | Medicine, Nephrology
Treatment of Chronic Renal Failure

The Bronx VA is participating in a research study to explore the beneficial effect of lowering homocysteine levels in patients with chronic renal failure. Chronic renal failure is associated with elevated levels of homocysteine which can be significantly reduced by treatment with folate, B6, and B12. It is thought that elevated levels of homocysteine may lead to vascular events that cause increase risk of arterial thrombosis, coronary disease of cerebrovascular events. This study will follow these clinical endpoints. Dr. Langhoff's basic research interests are HIV-1, Cytomegalovirus, and Polyoma Virus.

B.A., Soro Academy

M.D., University of Copenhagen, Faculty of Medicine

Ph.D., University of Copenhagen, Faculty of Medicine

The Rockefeller

Massachusetts General Hospital

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Langhoff during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Bronx RHIO

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.